Low Frequency of Protease Inhibitor Resistance Mutations and Insertions in HIV-1 Subtype C Protease Inhibitor-Naïve Sequences

AIDS Research and Human Retroviruses
Johanna LedwabaGillian M Hunt

Abstract

Human immunodeficiency virus-1 (HIV-1) protease sequences from 2,225 protease inhibitor (PI)-naïve HIV-1 subtype C-infected individuals collected over a 14-year period were analyzed for polymorphisms. Over 50% of sequences differed from an HIV-1 subtype B consensus sequence at 8 of the 99 amino acids at residues 12, 15, 19, 36, 41, 69, 89, and 93, but not in the functionally important regions. The frequency of primary resistance and accessory mutations occurred in <1% of the sequences. Of note, 11 sequences (0.5%) harbored amino acid insertions between residues 36 and 39, located in the elbow of the flap region. The insertions were found throughout the 13-year period. Occurrence of insertions in subtype C viruses is rare and viruses remain sensitive to currently used PIs (lopinavir/r, atazanavir/r, and darunavir/r). However, ongoing characterization of isolates is required to identify changes that may impact PI treatment since PIs are part of standard SA regimens.

References

May 17, 2001·Proceedings of the National Academy of Sciences of the United States of America·A Velazquez-CampoyE Freire
Jun 8, 2002·Journal of Molecular Biology·Stefano PianaMichele Parrinello
Aug 22, 2003·Organic & Biomolecular Chemistry·Ashraf Brik, Chi-Huey Wong
May 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tommy F Liu, Robert W Shafer
Jul 25, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·João Pereira-VazAntónio Meliço-Silvestre
Jul 28, 2010·Antimicrobial Agents and Chemotherapy·Soo-Yon RheeRobert W Shafer
Jun 23, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·J Nomthandazo DlaminiUNKNOWN Phidisa II Study Team
May 11, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G M HuntL Morris
Jun 12, 2013·Antiviral Therapy·Christopher J HoffmannLynn Morris
Apr 22, 2016·Journal of Virology·Soo-Yon RheeRobert W Shafer
Apr 7, 2018·Journal of Molecular Graphics & Modelling·Jake ZondaghYasien Sayed

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

PAUP
Seaview
Geneious

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.